Mechanisms elicited by type I interferons in cutaneous photocarcinogenesis
Mechanisms elicited by type I interferons in cutaneous photocarcinogenesis
批准号:
9238330
负责人:
Nabiha Yusuf
金额:
$32.34万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-20 至 2021-08-31
关键词:
AddressBindingCarcinogen exposureCell ProliferationChronicCutaneousDNA DamageDNA RepairDNA Repair GeneDNA biosynthesisDevelopmentDiseaseDoseEnvironmental CarcinogensExposure toGenerationsGenesHigh PrevalenceHumanIFNAR1 geneImmune responseImmunosuppressionInterferon Type IInterferonsKnockout MiceLeadLesionMalignant NeoplasmsMediatingMessenger RNAModelingMusMutationMyelogenousNatural ImmunityPathway interactionsPlayPost-Transcriptional RegulationPremalignantPreventionPrevention strategyProcessProductionProtein SplicingProteinsPyrimidine DimersRadiation Induced DNA DamageRegulationRoleSignal PathwaySignal TransductionSkinSkin CancerSkin NeoplasmsSolar EnergyStagingTLR4 geneTestingTranscriptional RegulationTumor Suppressor GenesUV carcinogenesisUVB inducedUltraviolet B RadiationUltraviolet RaysUp-RegulationVirus DiseasesWild Type Mousebasecell typecytokinegenetic signaturemRNA Decaymouse modelpathogenpreventreceptorrepairedresponseskin lesionsmall moleculetumortype I interferon receptorultraviolet
中文摘要
摘要
I型干扰素(IFN)是一种细胞因子,是免疫反应的重要调节因子,是
在包括皮肤癌在内的人类癌症中表达下调,太阳紫外线(UV)辐射是一种被证实的
环境致癌物质和暴露于太阳辐射导致皮肤癌的高患病率。
紫外光的致癌作用可归因于环丁烷嘧啶二聚体(CPD)的形成。
以及DNA修复和复制方面的错误。据认为,I型干扰素可减少细胞增殖,并使
各种疾病中的DNA修复。提示I型干扰素可能在UVB诱导的修复中起关键作用。
DNA损伤。我们的研究表明,缺乏I型干扰素受体1(IFNAR1)的小鼠修复能力下降
UVB可引起皮肤CPD,增强免疫抑制作用。I型IFN的监管一直很好
在转录水平上进行了研究,但在转录后水平的调控方面缺乏信息。
水平。K-同源型调节性剪接蛋白(KSRP)已被证明可以调节I型蛋白的产生
在转录后水平上,通过促进其信使核糖核酸的衰变来应对病毒感染。我们
已发现KSRP抑制小鼠皮肤中CPD的修复,并在人类皮肤肿瘤中高表达
与正常皮肤相比。我们假设I型干扰素将修复UVB诱导的DNA损伤并防止
肿瘤在小鼠体内的发展。这些I型干扰素介导的过程将受到KSRP的调控。测试我们的
假设,我们将使用缺乏IFNAR1的小鼠,IFNAR1是I型IFN信号的关键,而小鼠缺乏
KSRP。使用这些独特的小鼠模型,我们将能够(1)确定I型
干扰素是在UVB诱导DNA损伤后产生的,产生它们的细胞类型,以及
它们修复UVB辐射后形成的CPD;(2)剖析UVB辐射后CPD的调节机制
KSRP检测UVB诱导DNA损伤后的I型IFN;(3)阐明I型IFN是否参与发育
UVB诱导的皮肤肿瘤的发生以及KSRP是否参与了这一过程的调节。
英文摘要
ABSTRACT
Type I interferons (IFNs) are cytokines, that are important regulators of immune responses and are
downregulated in human cancers, including skin cancer, Solar ultraviolet (UV) radiation is a proven
environmental carcinogen, and exposure to solar radiation contributes to the high prevalence of skin cancer.
The carcinogenic effects of UV light can be attributed to the formation of cyclobutane pyrimidine dimers (CPD)
and errors in repair and replication of DNA. It is believed that type I IFNs reduce cellular proliferation and allow
DNA repair in various diseases. This suggests that type I IFNs may play a key role in repair of UVB induced
DNA damage. Our studies show that mice lacking the type I IFN receptor 1 (IFNAR1) had decreased repair of
UVB induced CPD in the skin and increased immunosuppression. Regulation of type I IFNs has been well
studied at the transcriptional level but there is a dearth of information on regulation at the post-transcriptional
level. K-homology type regulatory splicing protein (KSRP) has been shown to regulate the production of type I
IFNs, at the post-transcriptional level in response to viral infection, by promoting the decay of their mRNA. We
have found that KSRP inhibits the repair of CPD in mouse skin and is highly expressed in human skin tumors
compared to normal skin. We hypothesize that type I IFNs will repair UVB induced DNA damage and prevent
tumor development in mice. These type I IFN mediated processes will be regulated by KSRP. To test our
hypothesis, we will use mice, lacking IFNAR1, which is critical for signaling of type I IFNs, and mice lacking
KSRP. Using these unique mouse models, we will be able to (1) Determine the mechanisms by which type I
IFNs are produced after UVB induced DNA damage, the cell type that produces them, and the manner in
which they repair the CPD formed after exposure to UVB radiation; (2) Dissect the mechanism of regulation of
type I IFNs by KSRP, after UVB induced DNA damage; (3) Elucidate whether type I IFNs mediate development
of UVB induced skin tumors and whether KSRP contributes to their regulation in this process.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms elicited by type I interferons in cutaneous photocarcinogenesis
-
批准号:9764280
-
项目类别:
-
资助金额:$41.51万
-
财政年份:2016
-
负责人:Nabiha Yusuf
-
依托单位:
Mechanisms elicited by type I interferons in cutaneous photocarcinogenesis
-
批准号:10019328
-
项目类别:
-
资助金额:$32.34万
-
财政年份:2016
-
负责人:Nabiha Yusuf
-
依托单位:
Photodermatological Effects of Toll Like Receptor-4 (TLR4)
-
批准号:8107559
-
项目类别:
-
资助金额:$7.03万
-
财政年份:2010
-
负责人:Nabiha Yusuf
-
依托单位:
Photodermatological Effects of Toll Like Receptor-4 (TLR4)
-
批准号:7879788
-
项目类别:
-
资助金额:$7.33万
-
财政年份:2010
-
负责人:Nabiha Yusuf
-
依托单位:
Role of the Innate Immune System in Regulation of UVB Induced Skin Carcinogenesis
-
批准号:7677175
-
项目类别:
-
资助金额:$5.41万
-
财政年份:2009
-
负责人:Nabiha Yusuf
-
依托单位:
The Innate Immune System in Regulation of DVB Induced Skin Carcinogenesis
-
批准号:7691492
-
项目类别:
-
资助金额:$4.52万
-
财政年份:2008
-
负责人:Nabiha Yusuf
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: